Centese, a member of Bio Nebraska, shared their story recently with the Midlands Business Journal and talked about Thoraguard, its automated system for chest drainage after heart or lung surgery.
Article by Michelle Leach, Midlands Business Journal
From its Omaha headquarters, Centese is transforming patient care with Thoraguard, an automated system for chest drainage after heart or lung surgery. Implications for its flagship product are even more wide-ranging than this statement or function suggests.
For co-founder and CEO Evan Luxon, the Centese story is about medical innovation and recognizing and nurturing regional potential.